Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma

NCT04482933 is registered in ClinicalTrials.gov with Pediatric Brain Tumor Consortium as lead sponsor.

NCT NCT04482933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04482933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Trial of HSV G207 With a Single 5 Gy Radiation Dose in Children With Recurrent High-Grade Glioma
Lead sponsor
Pediatric Brain Tumor Consortium
Phase
Phase 2
Overall status
Withdrawn
Start date
September 1, 2025
Completion date
December 18, 2025
Enrollment
0 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma of brain, anaplastic glioma, giant cell glioblastoma, glioblastoma multiforme, high grade glioma, high-grade glioma, malignant glioma of brain, neoplasms